The Pre series A funding will be pivotal for Zingavita’s growth and marketing initiatives
Zingavita has announced the successful closure of Rs 10 crore Pre-series A funding round led by Anicut Capital. The investment is poised to catalyse Zingavita’s expansion into new product development focusing on targeted nutrition. Following Dheeraj Nagpal’s recent appointment as cofounder at the company, the round welcomes marquee investors from the Pharma and FMCG space.
The Pre series A funding, which saw participation from influential investors such as Venkat Krishnan (CEO at BionPharma), Puru Gupta (founder, True Elements), Vishesh Chandiok (CEO, Grant Thornton Bharat), Nikhil Bhandarkar (founding partner, Panthera Peak) and other seasoned angel investors, will be pivotal for Zingavita’s growth and marketing initiatives. Additionally, the funds will fuel the brand’s entry into the Premium Ayurvedic Supplement space.
Sachin Goel, Co-Founder, Zingavita said, “Zingavita is thrilled to welcome our new investors onboard. Anicut Capital continued backing and further investment have been a great encouragement. While we focus on creating formulations using superior quality ingredients intended to provide the best possible blend of ayurveda and modern nutritional science, this funding will enable us to accelerate our innovation cycle and meet our growth milestones in order to continue delivering on our promise of holistic nutrition for the entire family.”
Commenting on the fundraise, Dheeraj Nagpal, Co-Founder, Zingavita said, “With Anicut Capital’s strong backing and our commitment to delivering high-quality, science-backed nutrition tailored for every family, we at Zingavita are committed to achieve our vision of becoming India’s leading health supplement brand. This funding will propel us to new heights, enabling us to innovate, expand, and continue offering cutting-edge products that cater to the evolving needs of our discerning customers.”